Seroprevalence of SARS-COV-2 Antibodies in Scottish Healthcare Workers by Abo-Leyah, Hani et al.
                                                                    
University of Dundee
Seroprevalence of SARS-COV-2 Antibodies in Scottish Healthcare Workers









Early version, also known as pre-print
Link to publication in Discovery Research Portal
Citation for published version (APA):
Abo-Leyah, H., Gallant, S., Cassidy, D., Giam, Y. H., Killick, J., Marshall, B., Hay, G., Pembridge, T., Strachan,
R., Gallant, N., Parcell, B. J., George, J., Furrie, E., & Chalmers, J. D. (2020). Seroprevalence of SARS-COV-2
Antibodies in Scottish Healthcare Workers. medRxiv. https://doi.org/10.1101/2020.10.02.20205641
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 08. Dec. 2021
Seroprevalence of SARS-COV-2 Antibodies in Scottish 
Healthcare Workers 
Hani Abo-Leyah1, Stephanie Gallant1, Diane Cassidy1, Yan Hui Giam1, Justin Killick2, Beth Marshall2, 









1. Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, Dundee, 
DD1 9SY 
2. Department of Blood Sciences, NHS Tayside, Ninewells Hospital and Medical School, 
Dundee, DD1 9SY 




Short title: SARS-CoV-2 antibodies in Scottish Healthcare Workers  
Funding: NHS Tayside COVID-19 Research Fund, JDC is supported by the British Lung Foundation 
Chair of Respiratory Research. 
 
Conflicts of interest summary:  JDC reports grants and personal fees from GlaxoSmithKline, 
Boehringer-Ingelheim, Astrazeneca, Pfizer, Bayer Healthcare, Grifols, Napp, Insmed and Zambon 
outside the submitted work; All other authors report no conflicts of interest.  
  
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted October 2, 2020. ; https://doi.org/10.1101/2020.10.02.20205641doi: medRxiv preprint 
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
Abstract 
Introduction: Healthcare workers are believed to be at increased risk of SARS-CoV-2 infection. The 
extent of that increased risk compared to the general population and the groups most at risk have 
not been extensively studied. 
Methods: A prospective observational study of health and social care workers in NHS Tayside 
(Scotland, UK) from May to September 2020. The Siemens SARS-CoV-2 total antibody assay was used 
to establish seroprevalence in this cohort. Patients provided clinical information including 
demographics and workplace information. Controls, matched for age and sex to the general Tayside 
population, were studied for comparison.  
Results: A total of 2062 health and social care workers were recruited for this study. The participants 
were predominantly female (81.7%) and 95.2% were white. 299 healthcare workers had a positive 
antibody test (14.5%). 11 out of 231 control sera tested positive (4.8%). Healthcare workers 
therefore had an increased likelihood of a positive test (odds ratio 3.4 95% CI 1.85-6.16, p<0.0001). 
Dentists, healthcare assistants and porters were the job roles most likely to test positive. Those 
working in front-line roles with COVID-19 patients were more likely to test positive (17.4% vs. 13.4%, 
p=0.02). 97.1% of patients who had previously tested positive for SARS-CoV-2 by RT-PCR had positive 
antibodies, compared to 11.8% of individuals with a symptomatic illness who had tested negative. 
Anosmia was the symptom most associated with the presence of detectable antibodies.  
Conclusion: In this study, healthcare workers were three times more likely to test positive for SARS-
CoV-2 than the general population. The seroprevalence data in different populations identified in 
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Introduction 
 
Healthcare workers (HCWs) are known to be at increased risk of symptomatic infection with severe 
acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
1,2
. HCWs accounted for 21% of SARS cases 
during the outbreak in 20023 and high rates of symptomatic infections have been reported across 
Europe during the present pandemic, including in the UK4. Measures taken to mitigate this increased 
risk include adequate personal protective equipment (PPE)5, infection prevention and control (IPC) 
procedures within healthcare environments and staff testing. Across the UK, testing for healthcare 
and other key workers with symptoms has been widely available since April 2020
6
.  
A key challenge in containing the spread of SARS-CoV-2 has been the potential for  asymptomatic or 
atypical infection7. Even in the case of symptomatic individuals reverse transcriptase polymerase 
chain reaction (RT-PCR) on nasopharyngeal, oropharyngeal or combined upper airway swabs has a 
reported sensitivity of 70-90% and consequently will underestimate the number of infected 
individuals
8
. Therefore, the extent of infections in HCWs in different parts of the world remain 
largely unknown.  
Serological testing can be used to determine the incidence and prevalence of SARS-CoV-2 infection9. 
Identifying the extent of healthcare worker infections and the proportion of undetected infections is 
important to inform IPC measures during future waves of the pandemic.  
In this study, we investigated the seroprevalence of SARS-CoV-2 antibodies in a large population of 
Scottish HCWs.   
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Methods 
 
We conducted a prospective observational study recruiting HCWs employed within the National 
Health Service in Tayside (NHS Tayside). NHS Tayside is a NHS board in the East of Scotland that is 
responsible for delivering healthcare for over 400,000 people and employs around 14,000 staff.  
Healthcare staff were invited to participate in the study via advertisements, including email 
newsletters and posted adverts on the staff intranet page.  Recruitment took place during a single 
study visit at Ninewells Hospital, which is the health board’s largest teaching hospital. Recruitment 
took place between 28th May 2020 and the 2nd September 2020. All participants gave written 
informed consent to participate. The study was approved by the West of Scotland Research Ethics 
committee, approval number 20/WS/0078 
The inclusion criteria were: Employment as a health or social care worker and age over 16 years. 
Participants were excluded if they had any contraindication to venepuncture, and symptoms 
consistent with current SARS-CoV-2 infection at the time of enrolment or had tested positive for 
SARS-CoV-2 in the preceding 14 days.  
At the study visit, participants completed a questionnaire on demographics, previous symptoms, 
employment role, hours of work, contact with patients with COVID-19 infection and whether they 
had previously tested positive for SARS-CoV-2. Blood samples were taken for measurement of SARS-
CoV-2 antibodies in serum. 
 
SARS-CoV-2 antibody detection 
The Siemens SARS-CoV-2 total antibody assay was used in this study. This is a one stop bridging 
chemiluminescent immunoassay (CLIA) method that detects antibodies against the receptor-binding 
domain (RBD) of the SARS-CoV-2 spike (S1) protein. The assay is performed on the Siemens Atellica 
1300 platform. Validation of this assay was approved by the NHS Scotland national laboratories 
programme quality group  and was then further validated against other commercial antibody 
platforms in a previous study and found to have 95-100% sensitivity while titres remained constant 
beyond 81 days following a positive PCR test result10.  
Population control subjects 
A random selection of blood samples taken at NHS Tayside General Practice Surgeries were tested 
covering the same time period as the MATCH study cohort. Samples were age and sex matched to 
the Scottish population demographics to provide a representative sample of the local population to 
determine the background prevalence of SARS-CoV-2. Serum samples were run on the same 
Siemens analyser described above. 
Statistical analysis 
Data was analysed using IBM SPSS v25 and GraphPad Prism 8.1.2. Chi-squared and Fisher’s test were 
used as appropriate to compare proportions between groups. Logistic regression was used to derive 
the odds ratio values for the reported symptom analysis. A p-value <0.05 was considered statistically 
significant for all analyses.  
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Results 
 
A total of 2062 health and social care workers were recruited for this study. The participants were 
predominantly female (81.7%) and 95.2% were white. The mean age of participants was 44.8 years. 
Table 1 presents the demographic characteristics of the study participants and their healthcare 
roles. 
Seroprevalence of SARS-CoV-2 antibodies 
In our study, 299 HCW’s had a positive antibody test directed against SARS-CoV-2 spike protein. This 
represents a seroprevalence of 14.5%. 11 out of 231 control sera tested positive (4.8%) which was 
consistent with the broader Scottish surveillance data reported by Health protection Scotland (214 
positive tests out of 4751, 4.5%). Compared to both sets of population controls, HCWs had a greater 
than 3 times greater odds of a positive test (odds ratio 3.4 95% CI 1.85-6.16, p<0.0001 compared to 
local controls) and (OR 3.6, 95% CI 2.99-4.32, p<0.001 compared to Scotland wide controls). 
Table 2 shows the seroprevalence rate amongst subgroups in our study characterised demographic, 
job role and area of work. Male gender was more frequently associated with detected antibodies 
(18.5% vs 13.6%, p=0.02). Some job roles were significantly associated with a higher rate of SARS-
CoV-2 antibody detection. Healthcare workers in dentistry were the most frequently associated with 
detected antibodies (26%), followed by Health care assistants (HCA’s) (23.3%) and hospital porters 
(22.2%), p<0.0001 when comparing across groups. Figure 1 displays the rates of antibody prevalence 
amongst the HCW by profession.  
Healthcare staff who worked in areas of the hospital that treated suspected or confirmed cases of 
COVID-19 were more frequently associated with detected antibodies (17.4% vs. 13.4%, p=0.02). Staff 
who worked in critical care and the intensive care unit were not more frequently associated with 
detected antibodies (16% vs. 14.4%, p=0.61). 
 
Prior positive test results and symptomatic infections 
Only 624 study participants had ever had a SARS-COV-2 RT-PCR swab. 97.1% (102/105) of 
participants with positive RT-PCR had detectable antibodies. 11.8% of PCR negative participants had 
detectable antibody levels. In those who never had a RT-PCR test 9.5% of them had detectable 
antibodies.  Figure 2 displays the proportion of PCR positive and PCR negative participants with 
detected antibodies.   
45.4% (n=936) of the HCW’s recruited believed they had COVID-19 but only 25.1% (n=235) of these 
HCWs had detectable antibodies. Conversely, 18.7% (n=56) of those who had antibodies detected 
did not believe they ever had COVID-19.  
5.1% (n=56) of participants who reported no symptomatic illness during the study period had 
detectable antibodies compared to 25.6% (n=243) of participants who had at least one symptomatic 
illness. When compared with the general population individuals who did not have a symptomatic 
illness during the period of the study did not have an increase frequency of SARS-CoV-2 antibodies 
(OR 1.20 95% CI 0.30-4.83, p=0.26).  
Anosmia was the self-reported symptom that was most likely to correspond with detected 
antibodies (OR 12.3, 95% CI [9.3-16.3], p <0.001) but was only reported in 5.8% of HCW’s at any time 
(Table 3). A combination of cough, fever and anosmia was only reported at a frequency of 2.6% but 
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when present was associated with a 10-fold increase in odds of detectable antibody (OR 9.7, 95% CI 
[6.4-14.7], p <0.001). The absence of any cough, fever and anosmia was associated with a low odds 
of having a positive antibody test (OR 0.18, 95% CI [0.14-0.24], p <0.001).  
 
   
Discussion 
In this observational study of health and social care workers the SARS-COV-2 seroprevalence rate 
was 14.5%. To our knowledge this is the first such seroprevalence study to be published in Scotland.  
At the time of writing Health Protection Scotland (HPS) is leading a surveillance study for COVID-19 
in Scotland on behalf of the Scottish Government11. Present data from this study demonstrates a 
comparative seroprevalence of 4.5% nationally. Our data suggest therefore that health and social 
care workers are greater than 3 times more likely to be positive for spike protein antibodies and 
therefore likely to have been infected SARS-CoV-2. 
Other HCWs seroprevalence studies conducted in the rest of the UK also reported higher 
seropositivity when compared to the general population with seroprevalence rates of 24.4%12, 
25.4%13 and 10.7%14. 
Our study was notable for the inclusion of dentistry staff, who had the highest seroprevalence rate 
at 26%. This was well above the average seroprevalence rate of 14.5% amongst our HCW’s. Dentistry 
staff are expected to be a higher risk group given their focus of work is more likely to be aerosol 
generating and with close exposure to potentially infected mucosal surfaces15. Health care 
assistants, including such staff at nursing homes, had the second highest prevalence at 23%. The 
caring roles of these workers necessitate close patient contact and their increased risk was also 
reported in a recent Swedish study
16
. 
In other published HCW studies12, domestic or housekeeping staff had the highest seroprevalence of 
antibodies. This was not evident in our study where domestic staff had a below average 
seroprevalence rate of 13.1%. Other groups who had a seroprevalence rate above average were 
hospital porters and doctors. Doctors and porters are typically exposed to multiple patients in 
different working areas. By comparison nurses typically care for up to 6 patients in a defined area 
during their working day. The variability in work location in a particular time period could be a factor 
in the increased infection rate we observed.    
In our study, HCWs who worked in COVID-19 areas of the hospital had a slightly higher 
seroprevalence than those workers who did not. This finding is consistent with other studies, 
including HCW studies conducted in major urban areas where the community burden of COVID-19 
was a significant source of exposure17. Working in COVID-19 areas of the hospital is one way to 
define high risk exposure. Nevertheless, the majority of SARS-CoV-2 infections detected in this study 
occurred in staff who were not working directly with COVID-19 patients, and even so, this group still 
had a significantly higher prevalence of SARS-CoV-2 antibodies than the general population. While a 
seroprevalence study cannot establish the source of infection this strongly suggests transmission 
between healthcare staff within non-clinical environments since many staff roles that did not involve 
direct contact with patients were still associated with an increased rate of antibody positivity. 
Therefore, while much media attention has focused on the importance of PPE for front line staff, this 
data emphasises the importance of IPC measures in non-clinical areas within healthcare 
environments such as hospitals. The relative success of measures to protect high-risk frontline staff 
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is illustrated by the low rate of antibody detection in critical care staff. All staff working in critical 
care areas wore PPE in accordance with Health Protection Scotland guidance on working in aerosol 
generating procedures18 .We found no significant increased risk of infection for these staff. In the 
recently published study from Birmingham, UK12 staff in intensive care had a significantly lower risk 
of seropositivity. 
We asked our study participants to report if they thought they had COVID19 and list the symptoms 
they experienced. We describe that only one in four participants who thought they had contracted 
COVID19 demonstrated serological evidence of infection. The heightened suspicion of infection is 
justified amongst HCWs, but perceived infection does not correlate well with actual infection. This 
has some potentially important implications when considering the issue of chronic symptoms in 
individuals who believe they have had COVID19 infection
19
. However, we demonstrated in this study 
that certain symptoms are significantly more predictive of infection with SARS-CoV-2. Anosmia 
represented twelve-fold increased odds with having serologic evidence of infection. This particular 
symptom was also shown to be strongly predictive in similar analysis performed in other European 
studies16,20.  
Our study demonstrates that approximately one fifth (18.7%) of seropositive HCW’s were 
completely asymptomatic during the study period. This is consistent with studies that only recruited 
asymptomatic HCW’s12 and suggests that a significant proportion of the healthcare workforce will 
attend work without knowing that they may potentially transmit the infection their colleagues. 
This study has potential limitations, including potentially that individuals more likely to believe they 
have had a SARS-CoV-2 like illness would be more likely to volunteer for such a study. Nevertheless, 
we were successful in enrolling participants who had never experienced a symptomatic infection and 
demonstrate an increased seroprevalence even amongst this group. We enrolled patients up to 
September 2020 and therefore potentially up to 4-5 months post-infection. This raises the possibility 
of antibodies waning over time
21
. This seems unlikely as a prior study found no evidence of waning 
of the Siemens assay over 4 months
10
, while a similar Total spike protein antibody assay showed no 
waning over time in a study from Iceland22. Other studies have reported increased infection rate in 
the BAME population23,24,25, we were unable to investigate this as NHS Tayside has a workforce 
which is 97% white. Important strengths of the study including the large sample sample size, 
representation of multiple staff groups and the extensive SARS-CoV-2 testing of symptomatic 




In conclusion our study suggests that HCW are at increased risk of infection with SARS-COV-2 
compared with the general population. Our study suggests a differential risk amongst hospital staff 
and a high proportion of undetected symptomatic and asymptomatic infections. This will help to 
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Tables and Figures: 
Characteristic Number % of Total 
Gender:     
Male 378 18.3% 
Female 1684 81.7% 
Age Group:     
18-30 290 14.1% 
31-40 403 19.5% 
41-50 536 26.0% 
51-60 637 30.9% 
60+ 196 9.5% 
Ethnicity:     
White European 1964 95.5% 
Other White 16 0.8% 
South Asian 36 1.8% 
Chinese 10 0.5% 
Black 8 0.4% 
Arab 5 0.0% 
Traveller 2 0.1% 
Other Ethnic 16 0.8% 
Role:     
Doctor 237 11.5% 
Nurse 601 29.2% 
AHP 239 11.6% 
Pharmacy staff 69 3.4% 
HCA 172 8.4% 
Student 25 1.2% 
Domestic 84 4.1% 
Admin 403 19.6% 
Porter 27 1.3% 
Dentistry 50 2.4% 
Other  151 7.3% 
Table1: Demographic characteristics of study participants and roles. AHP= Allied health professional, 
HCA= Healthcare assistant. Other role includes: Lab technician, health scientist, maintenance, 
laundry, medical physics, other technician, patient transport, chaplaincy, volunteers. Note numbers 
for ethnicity do not add up to 2062 as participants could chose not to provide this data.  
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  Number (n) Seroprevalence P value 
Gender Male 70 18.5% 0.02 
 Female 229 13.6%  
Age Group 18-30 46 15.9% 0.5 
 31-40 60 14.9%  
 41-50 75 14.0%  
 51-60 97 15.2%  
 60+ 21 10.7%  
Ethnicity White European 284 14.5% 0.86 
 Other white  2 12.5%  
 South Asian 8 22.2%  
 Chinese 1 10.0%  
 Black 2 25.0%  
 Arab 1 20.0%  
 Other Ethnic 1 6.3%  
 Gypsy/Traveller 0 0.0%  
Role Doctor 50 21.1% <0.001 
 Nurse 80 13.3%  
 Allied Health 
Professional 
25 10.5%  
 Pharmacy staff 9 13.0%  
 HCA 40 23.3%  
 Student 4 16.0%  
 Domestic 11 13.1%  
 Admin 48 11.9%  
 Porter 6 22.2%  
 Other  13 8.6%  
 Dentistry 13 26.0%  
Area COVID 96 17.4% 0.024 
 Non COVID 203 13.4%  
Critical Care Yes 21 16.0% 0.61 
 No 278 14.4%  
 
Table 2: Seroprevalence rate by demographic, role and area of work. Non-significant p values in red 
font.  
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Figure 1: Percentage prevalence of SARS-COV-2 antibody amongst different HCW roles. 
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Figure 2: Proportion of antibody detection according to PCR status.  
 
Symptoms Frequency  OR P value 95% CI 
Fatigue 15.4% 4.5 0.0001 3.458 5.912 
Headache 12.3% 3.6 0.0001 2.809 4.653 
Cough 11.8% 2.1 0.0001 1.619 2.67 
Myalgia 11.7% 3.8 0.0001 2.931 4.856 
Fever 10.0% 2.5 0.0001 1.74 2.901 
Sore throat 9.8% 1.4 0.009 1.092 1.86 
Dyspnoea 9.2% 2.4 0.0001 1.825 3.076 
Runny nose 5.9% 1.2 0.378 0.835 1.61 
Anosmia 5.8% 12.3 0.0001 9.306 16.348 
Other 5.0% 3.5 0.001 2.615 4.705 
Diarrhoea 3.1% 2.5 0.0001 1.773 3.66 
Cough+Fever+Anosmia (CFA) 2.6% 9.7 0.0001 6.433 14.738 
Absence of CFA 13.1% 0.2 0.001 0.136 0.239 
Table 3: Frequency of reported symptoms and Odds ratio (OR) of each symptom corresponding to a 
detectable antibody against SARS-COV-2. CFA= combination of cough, fever and anosmia being 
reported. CI= 95% confidence interval. See appendix for list of other symptoms reports. 
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